Strengths

● The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.67 for the 2025 fiscal year.

● The company's share price in relation to its net book value makes it look relatively cheap.

● The company is one of the best yield companies with high dividend expectations.


Weaknesses

● With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.

● The company's earnings growth outlook lacks momentum and is a weakness.

● The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.

● The company does not generate enough profits, which is an alarming weak point.

● The company is highly valued given the cash flows generated by its activity.

● For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.

● For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.

● For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.

● Over the past twelve months, analysts' consensus has been significantly revised downwards.

● Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.